The Role of Toll-Like Receptors in Oncotherapy
Document Type: Research Article
Affiliations: 1: Department of Gastroenterology, Second Affiliated Hospital of Harbin Medical University, Harbin, P.R. China 2: Department of Critical Care Medicine, Third Affiliated Hospital of Harbin Medical University, Harbin, P.R. China 3: Department of Pain, Second Affiliated Hospital of Harbin Medical University, Harbin, P.R. China
Publication date: August 8, 2019
This article was made available online on March 25, 2019 as a Fast Track article with title: "The Role of Toll-like Receptors in Oncotherapy".
Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.
From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.